Clinical significance of lymphocytopenia in patients hospitalized with pneumonia caused by influenza virus

Affiliations

¹ Department of Public Health and Infectious Diseases, University of Rome Sapienza, Viale del Policlinico 155, Rome, Italy.
² Department of Public Health and Infectious Diseases, University of Rome Sapienza, Viale del Policlinico 155, Rome, Italy. mario.venditti@uniroma1.it.

Comment

Valeria Bellelli et al. Crit Care. 2019.

. 2019 Oct 29;23(1):330.

doi: 10.1186/s13054-019-2608-1.

¹ Department of Public Health and Infectious Diseases, University of Rome Sapienza, Viale del Policlinico 155, Rome, Italy.
² Department of Public Health and Infectious Diseases, University of Rome Sapienza, Viale del Policlinico 155, Rome, Italy. mario.venditti@uniroma1.it.

No abstract available

Conflict of interest statement

The authors declare that they have no competing interests.

Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality.
Bermejo-Martin JF, Cilloniz C, Mendez R, Almansa R, Gabarrus A, Ceccato A, Torres A, Menendez R; NEUMONAC group. Bermejo-Martin JF, et al. EBioMedicine. 2017 Oct;24:231-236. doi: 10.1016/j.ebiom.2017.09.023. Epub 2017 Sep 21. EBioMedicine. 2017. PMID: 28958655 Free PMC article.

1. Méndez R, Menéndez R, Amara-Elori I, Feced L, Piró A, Ramírez P, Sempere A, Ortega A, Bermejo-Martín JF, Torres A. Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortality. J Inf Secur. 2019;78(6):423–431. - PubMed
1. Bermejo-Martin JF, Cilloniz C, Mendez R, Almansa R, Gabarrus A, Ceccato A, Torres A, Menendez R, NEUMONAC group Lymphopenic community acquired pneumonia (L-CAP), an immunological phenotype associated with higher risk of mortality. EBioMedicine. 2017;24:231–236. doi: 10.1016/j.ebiom.2017.09.023. - DOI - PMC - PubMed
1. Zhou F, Li H, Gu L, Liu M, Xue C, Cao B, Wang C, for the National Influenza A(H1N1)pdm09 Clinical Investigation Group of China Risk factors for nosocomial infection among hospitalised severe influenza A(H1N1)pdm09 patients. Respir Med. 2018;134:86–91. doi: 10.1016/j.rmed.2017.11.017. - DOI - PubMed
1. Giannella M, Rodríguez-Sánchez B, Roa PL, Catalán P, Muñoz P, García de Viedma D, Bouza E, Gregorio Marañón Task Force for Pneumonia GANG Should lower respiratory tract secretions from intensive care patients be systematically screened for influenza virus during the influenza season? Crit Care. 2012;16(3):R104. doi: 10.1186/cc11387. - DOI - PMC - PubMed
1. Chongnarungsin D, Yella J, Guzman J. Coinfection of h1n1 influenza with Pneumocystis jiroveci pneumonia in immunocompetent patient. Crit Care Med. 2014;42(12):1634. doi: 10.1097/01.ccm.0000458638.30251.d2. - DOI